ÂÜÀòÂÒÂ×

Frédéric Peyrard is a seasoned professional in the pharmaceutical industry, currently serving as Global Sr. Director of New Product Strategy and New Business Development at Galapagos since October 2022, focusing on immunology, infectious diseases, and CAR-T therapeutic options. Prior to this, Peyrard held various leadership roles including Global Director of Commercial Insight at Almirall and Global Director for New Product Planning at Ferring Pharmaceuticals, where key achievements include the successful launch strategy for Adstiladrin. With extensive expertise in portfolio planning and market strategy across multiple therapeutic areas, Frédéric Peyrard has contributed to enhanced decision-making capabilities and revitalization of brand portfolios throughout a career spanning over 15 years, which includes significant tenures at Cephalon and Pfizer. Educational credentials include multiple master's degrees in pharmacy, business administration, and european market access, supported by a strong foundation in biochemistry and molecular biology.